Location of Repository

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore

By Vernon J. Lee, Kai Hong Phua, Mark I. Chen, Angela Chow, Stefan Ma, Kee Tai Goh and Yee Sin Leo

Abstract

Stockpiling drugs to prevent and treat influenza would be economically effective

Topics: Research
Publisher: Centers for Disease Control and Prevention
OAI identifier: oai:pubmedcentral.nih.gov:3291387
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (1999). Adult asthma prevalence, morbidity and mortality and their relationships with environmental and medical care factors in Singapore. Asian Pac J Allergy Immunol.
    2. (1970). An outbreak of “Hong Kong flu” in Singapore. Singapore Med J.
    3. (2001). Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob Agents Chemother.
    4. (2001). Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults. Clin Infect Dis.
    5. (2002). Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med.
    6. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial.
    7. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial.
    8. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial.
    9. (1996). Emerging infections: pandemic influenza. Epidemiol Rev.
    10. (1998). Epidemiology of influenza. In:
    11. (2005). Grotto I. Cost-benefit of stockpiling drugs for influenza pandemic. Emerg Infect Dis.
    12. (1999). Hospitalised low risk community-acquired pneumonia: outcome and potential for cost-savings. Ann Acad Med
    13. (1972). Impact of influenza epidemics on mortality in the United States from
    14. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
    15. (2000). Incidence of ischaemic heart disease and stroke in Chinese, Malays, and Indians in Singapore: Singapore Cardiovascular Cohort Study. Ann Acad Med
    16. (2002). Influenza in Singapore: assessing the burden of illness in the community. Ann Acad Med
    17. (2006). Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat Respir Med. 2005;4:107–16. Address for correspondence:
    18. (1999). Oseltamivir Compassionate Use Program Group. Use of oseltamivir during influenza outbreaks in Ontario nursing homes,
    19. (2006). Oseltamivir Post Exposure Prophylaxis Investigator Group. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.
    20. (2004). Oseltamivir prophylaxis during the influenza season in a paediatric cancer centre: prospective observational study. Hong Kong Med J.
    21. (2003). Pandemic influenza and healthcare demand in the Netherlands: scenario analysis. Emerg Infect Dis.
    22. (2001). Planning for the next pandemic of influenza. Rev Med Virol.
    23. (1999). Prevalence of diabetes and ethnic differences in cardiovascular risk factors. Diabetes Care.
    24. (2003). Prevention effectiveness—a guide to decision analysis and economic evaluation. 2nd ed.
    25. (1998). Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect.
    26. (2005). Singapore Department of Statistics. [cited
    27. (1994). Source for influenza pandemics.
    28. (1918). Spanish flu epidemic in
    29. (2001). survey on primary medical care in Singapore. Singapore Med J.
    30. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess.
    31. The annual production cycle for influenza vaccine.
    32. (1999). The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis.
    33. The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers.
    34. (2004). The prevalence of asthma and allergies in Singapore; data from two ISAAC surveys seven years apart. Arch Dis Child.
    35. (1999). Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.